GPT and diabetes mellitus: In rat liver cells, different concentrations of hesperidin exhibited inhibitory effects against ALT and AST activities; therefore, it can be considered a potential compound for designing a safe and effective agent for the management of diabetes mellitus-associated hepatic injury.